Literature DB >> 7566449

Neurobiology of Rett syndrome.

M V Johnston1, C Hohmann, M E Blue.   

Abstract

From a neurobiologic perspective, Rett syndrome appears to disrupt the growth of axonodendritic connections among neurons. The cell packing density within the grey matter is increased but the total number of neurons is relatively normal, except for selected neuronal populations such as the nucleus basalis of Meynert (NBM) and the substantia nigra. Neurochemical assays of postmortem brain from patients with Rett syndrome patients demonstrate reductions in choline acetyltransferase (ChAT), the acetylcholine synthetic enzyme localized in NBM nerve terminals. In an animal model, early postnatal injury to the cholinergic pathways projected from the NBM causes permanent disruption of developing cholinergic neurons and a behavioral disorder on maze testing. The results suggest a mechanism by which early deficits in cholinergic and dopamine neurons projecting to the cerebral cortex from the brainstem and basal forebrain could disrupt axonodendritic development in the cerebral cortex. Studies in our laboratory are examining the mechanisms for these effects as well as the distribution and densities of neurotransmitter receptors in postmortem brains from Rett patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566449     DOI: 10.1055/s-2007-979740

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  8 in total

1.  NTNG1 mutations are a rare cause of Rett syndrome.

Authors:  Hayley L Archer; Julie C Evans; David S Millar; Peter W Thompson; Alison M Kerr; Helen Leonard; John Christodoulou; David Ravine; Lazarus Lazarou; Lucy Grove; Christopher Verity; Sharon D Whatley; Daniela T Pilz; Julian R Sampson; Angus J Clarke
Journal:  Am J Med Genet A       Date:  2006-04-01       Impact factor: 2.802

2.  Enhancement of postsynaptic GABAA and extrasynaptic NMDA receptor-mediated responses in the barrel cortex of Mecp2-null mice.

Authors:  Fu-Sun Lo; Mary E Blue; Reha S Erzurumlu
Journal:  J Neurophysiol       Date:  2015-12-16       Impact factor: 2.714

3.  Optimized Administration of the M4 PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in Mecp2+/- Mice.

Authors:  Jakub Cikowski; Calista Holt; Bright Arthur; Mackenzie Smith; Sonia Gonzalez; Craig W Lindsley; Colleen M Niswender; Rocco G Gogliotti
Journal:  ACS Chem Neurosci       Date:  2022-06-07       Impact factor: 5.780

4.  Clinical and Preclinical Evidence for M1 Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome.

Authors:  Mackenzie Smith; Bright Arthur; Jakub Cikowski; Calista Holt; Sonia Gonzalez; Nicole M Fisher; Sheryl Anne D Vermudez; Craig W Lindsley; Colleen M Niswender; Rocco G Gogliotti
Journal:  Neurotherapeutics       Date:  2022-06-07       Impact factor: 6.088

5.  Neonatal dopamine depletion induces changes in morphogenesis and gene expression in the developing cortex.

Authors:  Irina N Krasnova; Elizabeth S Betts; Abiola Dada; Akilah Jefferson; Bruce Ladenheim; Kevin G Becker; Jean Lud Cadet; Christine F Hohmann
Journal:  Neurotox Res       Date:  2007-02       Impact factor: 3.911

6.  Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.

Authors:  Angèle Viola; Véronique Saywell; Laurent Villard; Patrick J Cozzone; Norbert W Lutz
Journal:  PLoS One       Date:  2007-01-17       Impact factor: 3.240

Review 7.  Morphogenetic roles of acetylcholine.

Authors:  J M Lauder; U B Schambra
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

Review 8.  Rett Syndrome: Crossing the Threshold to Clinical Translation.

Authors:  David M Katz; Adrian Bird; Monica Coenraads; Steven J Gray; Debashish U Menon; Benjamin D Philpot; Daniel C Tarquinio
Journal:  Trends Neurosci       Date:  2016-02       Impact factor: 13.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.